These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17559738)

  • 1. The complexity of medication regimens and test ordering for patients with diabetes from 1995 to 2003.
    Huang ES; Basu A; Finch M; Frytak J; Manning W
    Curr Med Res Opin; 2007 Jun; 23(6):1423-30. PubMed ID: 17559738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.
    van Bruggen R; Gorter K; Stolk RP; Zuithoff P; Klungel OH; Rutten GE
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):983-91. PubMed ID: 19623570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuity of Medication Use by US Adults With Diabetes, 2005-2019.
    Chehal PK; Uppal TS; Turbow S; Fernandes G; Haw JS; Shah MK; Rajpathak S; Narayan KMV; Ali MK
    JAMA Netw Open; 2023 Jan; 6(1):e2253562. PubMed ID: 36716032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in complexity of diabetes care in the United States from 1991 to 2000.
    Grant RW; Pirraglia PA; Meigs JB; Singer DE
    Arch Intern Med; 2004 May; 164(10):1134-9. PubMed ID: 15159272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in lipid profiles and descriptive characteristics of U.S. adults with and without diabetes and cholesterol-lowering medication use-National Health and Nutrition Examination Survey, 2003-2012, United States.
    Mercado CI; Gregg E; Gillespie C; Loustalot F
    PLoS One; 2018; 13(3):e0193756. PubMed ID: 29509776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cluster-randomized trial to estimate the effect of mobile screening and treatment feedback on HbA1c and diabetes-related complications in Tshwane primary health care clinics, South Africa.
    Webb EM; Rheeder P
    Prim Care Diabetes; 2017 Dec; 11(6):546-554. PubMed ID: 28690088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of diabetes care in the Otago region using a diabetes register, 1998-2003.
    Coppell KJ; Anderson K; Williams S; Manning P; Mann J
    Diabetes Res Clin Pract; 2006 Mar; 71(3):345-52. PubMed ID: 16183162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy.
    Langness J; Cook PF; Gill J; Boggs R; Netsanet N
    J Manag Care Spec Pharm; 2014 Aug; 20(8):809-14. PubMed ID: 25062074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
    Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
    Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Clinical Complexity, Treatment Burden, Health Care Use, and Diabetes-Related Outcomes Among Commercial and Medicare Advantage Plan Beneficiaries With Diabetes in the U.S., 2006-2018.
    Benning TJ; Heien HC; McCoy RG
    Diabetes Care; 2022 Oct; 45(10):2299-2308. PubMed ID: 35926104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction.
    Kogut SJ; Johnson S; Higgins T; Quilliam B
    J Manag Care Pharm; 2012 May; 18(4):297-310. PubMed ID: 22548690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of use of lipid-lowering medications: a cross-national study.
    Avorn J; Monette J; Lacour A; Bohn RL; Monane M; Mogun H; LeLorier J
    JAMA; 1998 May; 279(18):1458-62. PubMed ID: 9600480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents.
    Boye KS; Mody R; Lage MJ; Douglas S; Patel H
    Diabetes Ther; 2020 Jul; 11(7):1513-1525. PubMed ID: 32447737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.